Abstract
Mun KT, Bonomo JB, Liebeskind DS, et al. Fragility index meta-analysis of randomized controlled trials shows highly robust evidential strength for benefit of < 3 hour intravenous alteplase. Stroke. 2022;53:2069-74. 35543129.
MeSH terms
-
Brain Ischemia* / drug therapy
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Ischemic Stroke*
-
Stroke* / drug therapy
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator